According to the Tokyo Guidelines 2018, what is the recommended immediate management for a patient with grade II (moderate) acute cholangitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tokyo Guidelines 2018: Management of Grade II (Moderate) Acute Cholangitis

For Grade II (moderate) acute cholangitis, early biliary drainage should be performed within 24 hours along with immediate antibiotic administration. 1, 2, 3

Initial Medical Management

Antibiotic Therapy

  • Administer broad-spectrum antibiotics within 6 hours of diagnosis for moderate cholangitis patients who are not in septic shock 1, 2
  • Recommended empiric regimens include:
    • 4th-generation cephalosporins 2
    • Piperacillin/tazobactam 4, 2
    • Carbapenems (imipenem/cilastatin, meropenem, ertapenem) 4, 2
    • Aztreonam 4, 2
  • Target coverage against Gram-negative enteric bacteria and enterococci 1, 2

Supportive Care

  • Provide vigorous fluid resuscitation immediately 2, 5
  • Correct coagulopathies before any invasive procedure 1, 2

Biliary Drainage Strategy

Timing

Early biliary drainage within 24 hours significantly reduces 30-day mortality in Grade II cholangitis and must not be delayed. 1, 2, 5 Postponing drainage beyond this window dramatically increases morbidity and mortality 1, 5

First-Line Approach: ERCP

  • ERCP with biliary stent placement is the procedure of choice (Recommendation 1A) 1, 5, 3
  • Technical success rates exceed 90% with adverse event rates near 5% and mortality below 1% 1
  • During the acute phase, focus solely on biliary decompression—do not attempt definitive stone extraction 1
  • Preferred endoscopic options include:
    • Biliary stent placement above the obstruction 1
    • Nasobiliary drain placement 1
    • Optional limited sphincterotomy 1
  • Avoid high-pressure contrast injection to prevent cholangio-venous reflux and worsening bacteremia 1

Second-Line Approach: PTBD

  • Reserve percutaneous transhepatic biliary drainage (PTBD) only when ERCP fails or is not feasible (Recommendation 1B) 1, 5
  • Specific indications for PTBD:
    • Unsuccessful biliary cannulation during ERCP 1
    • Inaccessible papilla due to altered anatomy 1
    • Failed endoscopic access 1
  • PTBD carries significant risks: biliary peritonitis, hemobilia, pneumothorax, hepatic hematoma, liver abscess, and catheter-related discomfort 1, 5

Post-Drainage Management

Bile Cultures

  • Obtain bile cultures during the drainage procedure to enable targeted antimicrobial therapy 1, 2

Antibiotic Duration

  • Continue antibiotics for 3-5 days after successful biliary decompression 2
  • Total antibiotic course should be 7-10 days for uncomplicated acute cholangitis 4, 2
  • Extend therapy to 2 weeks if Enterococcus or Streptococcus is isolated to prevent infectious endocarditis 4, 2

Definitive Treatment

  • Treat the underlying etiology (e.g., endoscopic sphincterotomy for choledocholithiasis) after the patient's general condition has improved 6, 3
  • Do not attempt definitive stone extraction during the acute moderate phase 1, 3

Critical Pitfalls to Avoid

  • Never delay biliary drainage beyond 24 hours in Grade II cholangitis—this is the critical window for optimal outcomes and mortality reduction 1, 2, 5
  • Do not use PTBD as first-line therapy when ERCP is feasible—this exposes patients to unnecessary complications 1, 5
  • Avoid attempting complete stone clearance during acute drainage—focus exclusively on decompression to prevent exacerbation of sepsis 1, 3
  • Do not withhold empiric antibiotics to obtain cultures first—initiate therapy within the appropriate time window 1, 2

Response Assessment

  • If the patient does not respond to initial medical treatment within 24 hours, proceed immediately to biliary drainage 6, 3, 7
  • Grade II cholangitis is defined as acute cholangitis unaccompanied by organ dysfunction but unresponsive to initial medical treatment 7

References

Guideline

Management of Severe Cholangitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Acute Cholangitis Based on Severity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Cholangitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

TG13 flowchart for the management of acute cholangitis and cholecystitis.

Journal of hepato-biliary-pancreatic sciences, 2013

Research

Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines.

Journal of hepato-biliary-pancreatic surgery, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.